Cargando…
Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination
BACKGROUND: Tumor necrosis factor (TNF) is known to promote T cell migration and increase the expression of vascular endothelial growth factor (VEGF) and chemokines. The administration of Xpro-1595, a dominant-negative TNF (DN-TNF) engineered to selectively inactivate soluble TNF (solTNF), has been...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691138/ https://www.ncbi.nlm.nih.gov/pubmed/38036985 http://dx.doi.org/10.1186/s12865-023-00576-x |
_version_ | 1785152679199113216 |
---|---|
author | Davuluri, Kusuma Sai Singh, Amit Kumar Yadav, Vimal Kumar Singh, Ajay Vir Singh, Shoor Vir Chauhan, Devendra Singh |
author_facet | Davuluri, Kusuma Sai Singh, Amit Kumar Yadav, Vimal Kumar Singh, Ajay Vir Singh, Shoor Vir Chauhan, Devendra Singh |
author_sort | Davuluri, Kusuma Sai |
collection | PubMed |
description | BACKGROUND: Tumor necrosis factor (TNF) is known to promote T cell migration and increase the expression of vascular endothelial growth factor (VEGF) and chemokines. The administration of Xpro-1595, a dominant-negative TNF (DN-TNF) engineered to selectively inactivate soluble TNF (solTNF), has been extensively studied and proven effective in reducing TNF production without suppressing innate immunity during infection. The literature also supports the involvement of glutamic acid-leucine-arginine (ELR+) chemokines and VEGF in angiogenesis and the spread of infections. MATERIALS AND METHODS: In this study, we administered Xpro-1595 to guinea pigs to selectively inhibit solTNF, aiming to assess its impact on Mycobacterium tuberculosis (M.tb) dissemination, bacterial growth attenuation, and immunological responses. We conducted immunohistochemical analyses, immunological assays, and colony enumeration to comprehensively study the effects of Xpro-1595 by comparing with anti-TB drugs treated M.tb infected guinea pigs. Throughout the infection and treatment period, we measured the levels of Interleukin-12 subunit alpha (IL-12), Interferon-gamma (IFN-γ), TNF, Tumor growth factor (TGF), and T lymphocytes using ELISA. RESULTS: Our findings revealed a reduction in M.tb dissemination and inflammation without compromising the immune response during Xpro-1595 treatment. Notably, Xpro-1595 therapy effectively regulated the expression of VEGFA and ELR + chemokines, which emerged as key factors contributing to infection dissemination. Furthermore, this treatment influenced the migration of CD4 T cells in the early stages of infection, subsequently leading to a reduced T cell response and controlled proinflammatory signalling, thus mitigating inflammation. CONCLUSION: Our study underscores the pivotal role of solTNF in the dissemination of M.tb to other organs. This preliminary investigation sheds light on the involvement of solTNF in the mechanisms underlying M.tb dissemination, although further in-depth research is warranted to fully elucidate its role in this process. |
format | Online Article Text |
id | pubmed-10691138 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106911382023-12-02 Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination Davuluri, Kusuma Sai Singh, Amit Kumar Yadav, Vimal Kumar Singh, Ajay Vir Singh, Shoor Vir Chauhan, Devendra Singh BMC Immunol Research BACKGROUND: Tumor necrosis factor (TNF) is known to promote T cell migration and increase the expression of vascular endothelial growth factor (VEGF) and chemokines. The administration of Xpro-1595, a dominant-negative TNF (DN-TNF) engineered to selectively inactivate soluble TNF (solTNF), has been extensively studied and proven effective in reducing TNF production without suppressing innate immunity during infection. The literature also supports the involvement of glutamic acid-leucine-arginine (ELR+) chemokines and VEGF in angiogenesis and the spread of infections. MATERIALS AND METHODS: In this study, we administered Xpro-1595 to guinea pigs to selectively inhibit solTNF, aiming to assess its impact on Mycobacterium tuberculosis (M.tb) dissemination, bacterial growth attenuation, and immunological responses. We conducted immunohistochemical analyses, immunological assays, and colony enumeration to comprehensively study the effects of Xpro-1595 by comparing with anti-TB drugs treated M.tb infected guinea pigs. Throughout the infection and treatment period, we measured the levels of Interleukin-12 subunit alpha (IL-12), Interferon-gamma (IFN-γ), TNF, Tumor growth factor (TGF), and T lymphocytes using ELISA. RESULTS: Our findings revealed a reduction in M.tb dissemination and inflammation without compromising the immune response during Xpro-1595 treatment. Notably, Xpro-1595 therapy effectively regulated the expression of VEGFA and ELR + chemokines, which emerged as key factors contributing to infection dissemination. Furthermore, this treatment influenced the migration of CD4 T cells in the early stages of infection, subsequently leading to a reduced T cell response and controlled proinflammatory signalling, thus mitigating inflammation. CONCLUSION: Our study underscores the pivotal role of solTNF in the dissemination of M.tb to other organs. This preliminary investigation sheds light on the involvement of solTNF in the mechanisms underlying M.tb dissemination, although further in-depth research is warranted to fully elucidate its role in this process. BioMed Central 2023-11-30 /pmc/articles/PMC10691138/ /pubmed/38036985 http://dx.doi.org/10.1186/s12865-023-00576-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Davuluri, Kusuma Sai Singh, Amit Kumar Yadav, Vimal Kumar Singh, Ajay Vir Singh, Shoor Vir Chauhan, Devendra Singh Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination |
title | Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination |
title_full | Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination |
title_fullStr | Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination |
title_full_unstemmed | Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination |
title_short | Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination |
title_sort | dominant negative biologics normalise the tumour necrosis factor (tnf-α) induced angiogenesis which exploits the mycobacterium tuberculosis dissemination |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691138/ https://www.ncbi.nlm.nih.gov/pubmed/38036985 http://dx.doi.org/10.1186/s12865-023-00576-x |
work_keys_str_mv | AT davulurikusumasai dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination AT singhamitkumar dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination AT yadavvimalkumar dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination AT singhajayvir dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination AT singhshoorvir dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination AT chauhandevendrasingh dominantnegativebiologicsnormalisethetumournecrosisfactortnfainducedangiogenesiswhichexploitsthemycobacteriumtuberculosisdissemination |